 |
Risk Assessment (Latest Articles)
Latest indexed articles for 'Risk Assessment'
Articles 1 to 10 of 200:
Gene expression profiling: decoding breast cancer.
29 Nov 2009 
Gene expression assays that are used in daily clinical practice for treating early breast cancer patients have been introduced in the clinic only recently. This review discusses the development of these arrays, summarizes the validation of those ...
rec_pub_19879448-gene-expression-profiling-decoding-breast-cancer.htm
29 Nov 2009 BACKGROUND: Increased activity of multidrug resistance (MDR) genes has been associated with treatment failure in acute leukemias, although with controversial reports. The objective of the present study was to assess the expression profile of the ...
rec_pub_19672972-mrna-expression-profile-multidrug-resistance-genes-childhood-acute.htm
18 Nov 2009 BACKGROUND AND AIM: Previous studies have reported different risk factors for early and late intrahepatic recurrence after resection of hepatocellular carcinoma (HCC). However, the prognostic significance of the risk factors for early and late ...
rec_pub_19032452-the-preoperative-positivity-serum-hepatitis-b-e-antigen-did-affect.htm
17 Nov 2009 In three separate manipulations, a group of children at risk for developmental coordination disorder (DCD; five males, seven females; mean age 11y 6mo [SD 6.8mo] who were at or below the 15th centile on the Movement ABC) and a group of typically ...
rec_pub_19018835-children-risk-developmental-coordination-disorder-judgement-changes.htm
13 Nov 2009 Second primary neoplasms (SPNs) are a recognised late effect of treatment for childhood cancer. Thyroid SPNs can develop after exposure to low-dose radiation, due to the radio-sensitivity of the thyroid gland. The British Childhood Cancer Survivor ...
rec_pub_19610069-risk-thyroid-cancer-survivors-childhood-cancer-results-british.htm
The Viracept-EMS case: impact and outlook.
10 Nov 2009 This perspective first considers the potential impact of the Viracept-EMS case in the framework of the current understanding of the low-dose effects of DNA-reactive chemicals and the approaches used to estimate health risks from genotoxins occurring ...
rec_pub_19866516-the-viracept-ems-case-impact-outlook.htm
Nov 2009 OBJECTIVE: To investigate the incidence of and risk factors for cognitive impairment in a large, well-defined clinical trial cohort of patients with early Parkinson disease (PD). METHODS: The Mini-Mental State Examination (MMSE) was administered ...
rec_pub_19884574-incidence-risk-factors-cognitive-impairment-early-parkinson-disease.htm
Triggering of nocturnal arrhythmias by sleep-disordered breathing events.
Nov 2009 OBJECTIVES: This study sought to evaluate respiratory disturbances as potential triggers for arrhythmia in patients with sleep-disordered breathing (SDB). BACKGROUND: SDB is associated with an increased risk of atrial fibrillation and nonsustained ...
rec_pub_19874994-triggering-nocturnal-arrhythmias-sleep-disordered-breathing-events.htm
Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article.
30 Oct 2009 OBJECT: Moyamoya disease (MMD) is a rare cerebrovascular disease mainly described in the Asian literature. To address a lack of data on clinical characteristics and long-term outcomes in the treatment of MMD in North America, the authors analyzed ...
rec_pub_19463046-clinical-outcome-450-revascularization-procedures-moyamoya-disease.htm
30 Oct 2009 OBJECT: Surgery for skull base meningiomas (SBMs) can lead to complications because these lesions are difficult to approach and can involve cranial nerves and arteries. The authors propose a scoring system to evaluate the relative risks and benefits ...
rec_pub_19119879-abc-surgical-risk-scale-skull-base-meningioma-new-scoring-system.htm
Results: [1-10] [11-20] [21-30] [31-40] [41-50] [51-60] [61-70] [71-80] [81-90] [91-100] [101-110] [111-120] [121-130] [131-140] [141-150] [151-160] [161-170] [171-180] [181-190] [191-200]